Olympus to Acquire BioProtect for $270 Million
May 27, 2026
Olympus signed a definitive agreement to acquire BioProtect for $270 million to expand its urology and oncology technology portfolio for prostate cancer care. The deal is expected to close by the end of Q2 2026, subject to customary closing conditions, with portions of the purchase price held in escrow tied to uninterrupted operation.
- Buyers
- Olympus Corporation
- Targets
- BioProtect Ltd.
- Industry
- Medical Devices
- Location
- Israel
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.